Benitec Biopharma Inc. (BNTC)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q3-2026 | 8-K (2026-05-14) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-Q | Q2-2026 | 8-K (2026-02-12) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2025-11-14) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-09-22) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-05-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2025-02-14) · 99.1 | 8-K (2024-02-13) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2024-11-14) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2024-09-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2025-02-14) · 99.1 | 8-K (2024-02-13) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2023-11-13) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2023-09-21) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statements of Stockholders' Equity (P) | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Basis of Presentation and Summary of Significant Accounting Policies | ||
| Business | ||
| Cash, Cash Equivalents, and Restricted Cash | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Leases | ||
| Liquidity | ||
| Loss Per Share | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid and Other Assets | ||
| Property and Equipment, Net | ||
| Related Party Transactions | ||
| Restatement of Prior Period Financial Statements | — |
|
| Revenue | — |
|
| Segment Reporting | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Trade and Other Payables | ||
| Updated Quarterly Results | — |
|